Skip Nav Destination
1-7 of 7
Camila Oliveira, Henrique Mariz, Gisele Fernandes, Denise Costa, Maria Alina Cavalcante, Lucila Valente
Nephron (2020) 144 (3): 118–125.
Published Online: 07 January 2020
... on evidence suggesting different renal outcomes. However, subsequent studies have shown conflicting results. Objective: This study was performed to compare long-term renal outcomes between the IV-S and IV-G classes. Methods: This is a retrospective cohort study of adult patients with biopsy-proven class IV LN...
Nephron (2019) 143 (3): 193–196.
Published Online: 16 May 2019
... for deceased donor kidneys, rates of DGF remain high, on average, 30% for recipients of deceased donor kidneys. DGF is associated with inferior allograft outcomes, and there are no FDA-approved therapies to mitigate this disorder. There is renewed interest in this therapeutic arena, and there are several...
Nephron (2018) 140 (2): 94–98.
Published Online: 13 July 2018
... to the avoidance of donor organs offered to a transplant center. DGF is associated with worse short-and long-term outcomes and associated with higher rejection rates. There are no FDA-approved therapies to mitigate the ischemic injury that occurs. Risk factors include both donor and recipient characteristics...
Sajeda Youssouf, Azri Nache, Chandrakumaran Wijesekara, Rachel J. Middleton, David Lewis, Aladdin E. Shurrab, Edmond O'Riordan, Lesley P. Lappin, Donal O'Donoghue, Philip A. Kalra, Janet Hegarty
Nephron (2017) 136 (2): 75–84.
Published Online: 25 February 2017
... gap remains between the international guidelines and the actual delivery of care. In this paper, we report outcomes for the first year of a multifaceted dialysis improvement programme in our network. Methods: One year collaborative involving 3 haemodialysis units and a peritoneal dialysis (PD...
Nephron (2017) 136 (2): 54–61.
Published Online: 18 February 2017
... the characteristics, outcomes, and health care utilization and costs of patients with HCV with and without renal impairment. Methods: This retrospective analysis used 2 administrative claims databases: the US commercially insured population in Truven Health MarketScan® data (aged 20-64 years), and the US Medicare fee...
Samir C. Gautam, Charles H. Brooks, Rasheed A. Balogun, Wenjun Xin, Jennie Z. Ma, Emaad M. Abdel-Rahman
Nephron (2015) 131 (3): 185–190.
Published Online: 03 November 2015
...Samir C. Gautam; Charles H. Brooks; Rasheed A. Balogun; Wenjun Xin; Jennie Z. Ma; Emaad M. Abdel-Rahman Background: Acute kidney injury (AKI) is a frequent complication of hospitalized patients and is associated with poor outcomes. Hospitalized patients with AKI may need prolonged dialysis...
François Paquette, Amélie Bernier-Jean, Véronique Brunette, Hélène Ammann, Valéry Lavergne, Vincent Pichette, Stéphan Troyanov, Josée Bouchard
Nephron (2015) 131 (3): 153–160.
Published Online: 22 September 2015
... at risk of AKI. Whether present patient characteristics and management have changed this risk is uncertain. We determined the current incidence, risk factors and outcomes of AG-AKI. Methods: We retrospectively identified adult patients who received gentamicin or tobramycin for ≥5 days in 2 large...